Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2000-07-07
2003-08-19
Myers, Carla J. (Department: 1632)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S024310, C536S024330, C536S024500, C435S006120, C514S04400A
Reexamination Certificate
active
06608188
ABSTRACT:
TECHNICAL FIELD
This invention relates to a novel gene having a reverse transcriptase motif, a protein encoded by the gene, an antibody against the protein, and a method for detecting reverse transcriptase activity, a method for detecting a cancer cell, and a reverse transcriptase activity inhibitor or a method for screening a reverse transcriptase activity inhibitor, each of the methods and the inhibitor using any of the novel gene, the protein, and the antibody.
The invention also relates to a method for diagnosing cancer by the use of the above detecting method, a cancer diagnostic agent containing a probe complementary to the gene, and a cancer diagnostic agent containing the antibody.
BACKGROUND ART
Telomerase is an enzyme known to have the function of repairing the length of telomere which is shortened by each cell division (Greider C. W. and Blackburn E. H., (1987) Cell, 51, 887-898; Morin G. B. (1989) Cell, 59, 521-529).
Most cancer cells show telomerase activity (Kim N. W. et al., (1994) Science, 206, 2011-2015), a finding strongly suggesting that telomerase takes part in maintaining the infinite proliferation of cancer cells.
The measurement of telomerase activity, therefore, is important for diagnosis of cancer, and a substance inhibiting telomerase activity can be expected to serve as an anticancer drug causing few adverse reactions to normal cells (Counter C. M. et al., (1989) EMBO J., 11, 1921-1929; Counter C. M. et al., (1994) Proc. Natl. Acad. Sci. USA, 91, 2900-2904; Chadenneau C. et al., (1995) Cancer Res., 55, 2533-2536; Hiyama E. et al., (1995) Nature Med., 1, 249-255; Shay J. W. et al., (1995) Mol. Cell. Biol., 15, 425-432).
One of conventional methods for measuring telomerase activity is to measure telomerase enzyme activity.
According to this method, a cell extract needs to be prepared beforehand, with enzyme activity being maintained. Then, a telomere elongation reaction (telomerase reaction) is performed. The elongated telomere is measured for the amount of the resulting DNA, directly or after amplification by polymerase chain reaction (PCR). This method was not a convenient, effective method for measuring telomerase activity.
Another method for measuring telomerase activity is to measure the expression of a telomerase gene. Such a method requires the identification of the gene correlated to telomerase activity.
As one of such genes, a gene encoding a protein having a reverse transcriptase motif with a molecular weight of about 130 kDa was recently isolated from mRNA derived from a human testis or a cancer cell (Meyerson M., et al., (1997) Cell, 90, 785-795; Nakamura T. M. et al., (1997) Science, 277, 955-959).
Since the expression of this gene showed high correlation with telomerase activity, this gene has been speculated to code for a human telomerase catalytic subunit.
However, much is yet unknown about telomerase.
For example, it is still unknown whether a plurality of genes having a reverse transcriptase motif exists, and whether a gene, or a plurality of genes, showing telomerase activity exist. It is also unknown whether the telomerase activity of a normal germ cell and that of a cancer cell always come from the same genetic product, and whether the telomerase activities of all cancer cells can be explained by a single gene. Solutions to these questions are desperately wanted in the fields of cancer diagnosis and treatment focusing on telomerase.
DISCLOSURE OF THE INVENTION
The present invention aims to provide a novel gene encoding a protein having a reverse transcriptase motif, the novel gene having correlation with reverse transcriptase activity.
The invention also aims to provide a protein encoded by the gene, and an antibody against the protein.
The invention further aims to provide a method for measuring reverse transcriptase activity, and a method for detecting a cancer cell, each method using the gene, the protein, or the antibody.
The reverse transcriptase as used herein refers collectively to nucleic acid polymerases which perform DNA synthesis using RNA as template. A known representative reverse transcriptase is that found in retroviruses.
Telomerase synthesizes a telomere DNA sequence by using its own subunit, single-stranded RNA, as template. Thus, telomerase is positioned as an associate of RNA-dependent DNA polymerases, i.e., an associate of reverse transcriptases.
In the present specification, reverse transcriptase activity refers, preferably, to telomerase enzyme activity.
REFERENCES:
patent: WO 98/37181 (1998-08-01), None
patent: WO 99/01560 (1999-01-01), None
Meyerson et al., HEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalizatgion (1997),Cell(90):785-795.
Nakamura, et al. Telomerase Catalytic Subunit Homologs From Fission Yeast and Human (1997)Science (277):955-959.
M. Meyerson et al., “hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortilization”, Aug. 22, 1997,Cell, vol. 90, pp. 785-795.
Toru Nakamura et al., “Telomerase Catalytic Subunit Homologs from Fission Yeast and Human”, Aug. 15, 1997,Science, vol. 277, pp. 955-959.
Tsuchiya Masayuki
Yoshida Kenji
Morgan & Lewis & Bockius, LLP
Myers Carla J.
LandOfFree
CRT-1 gene having reverse transcriptase motif does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CRT-1 gene having reverse transcriptase motif, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CRT-1 gene having reverse transcriptase motif will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3118517